tbuckley/cabot-search huggingface dataset:
StrokeClassifier: ischemic stroke etiology classification by ensemble consensus modeling using electronic health records
Authors: Ho-Joon Lee, Lee H. Schwamm, Lauren H. Sansing, Hooman Kamel, Adam de Havenon, Ashby C. Turner, Kevin N. Sheth, Smita Krishnaswamy, Cynthia Brandt, Hongyu Zhao, Harlan Krumholz, Richa Sharma
Journal: npj Digital Medicine (2024)

Abstract Determining acute ischemic stroke (AIS) etiology is fundamental to secondary stroke prevention efforts but can be diagnostically challenging. We trained and validated an automated classification tool, StrokeClassifier , using electronic health record (EHR) text from 2039 non-cryptogenic AIS patients at 2 academic hospitals to predict the 4-level outcome of stroke etiology adjudicated by agreement of at least 2 board-certified vascular neurologists’ review of the EHR. StrokeClassifier is an ensemble consensus meta-model of 9 machine learning classifiers applied to features extracted from discharge summary texts by natural language processing. StrokeClassifier was externally validated in 406 discharge summaries from the MIMIC-III dataset reviewed by a vascular neurologist to ascertain stroke etiology. Compared with vascular neurologists’ diagnoses, StrokeClassifier achieved the mean cross-validated accuracy of 0.74 and weighted F1 of 0.74 for multi-class classification. In MIMIC-III, its accuracy and weighted F1 were 0.70 and 0.71, respectively. In binary classification, the two metrics ranged from 0.77 to 0.96. The top 5 features contributing to stroke etiology prediction were atrial fibrillation, age, middle cerebral artery occlusion, internal carotid artery occlusion, and frontal stroke location. We designed a certainty heuristic to grade the confidence of StrokeClassifier’s diagnosis as non-cryptogenic by the degree of consensus among the 9 classifiers and applied it to 788 cryptogenic patients, reducing cryptogenic diagnoses from 25.2% to 7.2%. StrokeClassifier is a validated artificial intelligence tool that rivals the performance of vascular neurologists in classifying ischemic stroke etiology. With further training, StrokeClassifier may have downstream applications including its use as a clinical decision support system.
Integrative multi-omics profiling in human decedents receiving pig heart xenografts
Authors: Eloi Schmauch, Brian Piening, Maedeh Mohebnasab, Bo Xia, Chenchen Zhu, Jeffrey Stern, Weimin Zhang, Alexa K Dowdell, Jacqueline I Kim, David Andrijevic, Karen Khalil, Ian S Jaffe, Bao-Li Loza, Loren Gragert, Brendan R Camellato, Michelli F Oliveira, Darragh P O'Brien, Han M Chen, Elaina Weldon, Hui Gao, Divya Gandla, Andrew Chang, Riyana Bhatt, Sarah Gao, Xiangping Lin, Kriyana P Reddy, Larisa Kagermazova, Alawi H Habara, Sophie Widawsky, Feng-Xia Liang, Joseph Sall, Alexandre Loupy, Adriana Heguy, Sarah E B Taylor, Yinan Zhu, Basil Michael, Lihua Jiang, Ruiqi Jian, Anita S Chong, Robert L Fairchild, Suvi Linna-Kuosmanen, Minna U Kaikkonen, Vasishta Tatapudi, Marc Lorber, David Ayares, Massimo Mangiola, Navneet Narula, Nader Moazami, Harvey Pass, Ramin S Herati, Adam Griesemer, Manolis Kellis, Michael P Snyder, Robert A Montgomery, Jef D Boeke, Brendan J Keating
Journal: Nature Medicine (2024)
Somatic structural variants drive distinct modes of oncogenesis in melanoma
Authors: Jake R Conway, Riaz Gillani, Jett Crowdis, Brendan Reardon, Jihye Park, Seunghun Han, Breanna Titchen, Mouadh Benamar, Rizwan Haq, Eliezer M Van Allen
Journal: Journal of Clinical Investigation (2024)

The diversity of structural variants (SVs) in melanoma and how they impact oncogenesis are incompletely known. We performed harmonized analysis of SVs across melanoma histological and genomic subtypes, and we identified distinct global properties between subtypes. These included the frequency and size of SVs and SV classes, their relation to chromothripsis events, and the role of topologically associated domain (TAD) boundary altering SVs on cancer-related genes. Following our prior identification of double-stranded break repair deficiency in a subset of triple wild-type cutaneous melanoma, we identified MRE11 and NBN loss-of-function SVs in melanomas with this mutational signature. Experimental knockouts of MRE11 and NBN, followed by olaparib cell viability assays in melanoma cells, indicated that dysregulation of each of these genes may cause sensitivity to PARPi in cutaneous melanomas. Broadly, harmonized analysis of melanoma SVs revealed distinct global genomic properties and molecular drivers, which may have biological and therapeutic impact.
TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti–PD-1 tumor immunotherapy
Authors: Blanda Di Luccia, Martina Molgora, Darya Khantakova, Natalia Jaeger, Hao-Wei Chang, Rafael S. Czepielewski, Beth A. Helmink, Emily J. Onufer, José L. Fachi, Bishan Bhattarai, Tihana Trsan, Patrick F. Rodrigues, JinChao Hou, Jennifer K. Bando, Cristiane Sécca da Silva, Marina Cella, Susan Gilfillan, Robert D. Schreiber, Jeffrey I. Gordon, Marco Colonna
Journal: Science Immunology (2024)

The gut microbiota and tumor-associated macrophages (TAMs) affect tumor responses to anti–programmed cell death protein 1 (PD-1) immune checkpoint blockade. Reprogramming TAM by either blocking or deleting the macrophage receptor triggering receptor on myeloid cells 2 (TREM2) attenuates tumor growth, and lack of functional TREM2 enhances tumor elimination by anti–PD-1. Here, we found that anti–PD-1 treatment combined with TREM2 deficiency in mice induces proinflammatory programs in intestinal macrophages and a concomitant expansion of Ruminococcus gnavus in the gut microbiota. Gavage of wild-type mice with R. gnavus enhanced anti–PD-1–mediated tumor elimination, recapitulating the effect occurring in the absence of TREM2. A proinflammatory intestinal environment coincided with expansion, increased circulation, and migration of TNF-producing CD4 + T cells to the tumor bed. Thus, TREM2 remotely controls anti–PD-1 immune checkpoint blockade through modulation of the intestinal immune environment and microbiota, with R. gnavus emerging as a potential probiotic agent for increasing responsiveness to anti-PD-1.
LRIG1 engages ligand VISTA and impairs tumor-specific CD8 <sup>+</sup> T cell responses
Authors: Hieu Minh Ta, Dia Roy, Keman Zhang, Tyler Alban, Ivan Juric, Juan Dong, Prerana B. Parthasarathy, Sachin Patnaik, Elizabeth Delaney, Cassandra Gilmour, Amin Zakeri, Nidhi Shukla, Amit Rupani, Yee Peng Phoon, Caini Liu, Stefanie Avril, Brian Gastman, Timothy Chan, Li Lily Wang
Journal: Science Immunology (2024)

Immune checkpoint blockade is a promising approach to activate antitumor immunity and improve the survival of patients with cancer. V-domain immunoglobulin suppressor of T cell activation (VISTA) is an immune checkpoint target; however, the downstream signaling mechanisms are elusive. Here, we identify leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) as a VISTA binding partner, which acts as an inhibitory receptor by engaging VISTA and suppressing T cell receptor signaling pathways. Mice with T cell-specific LRIG1 deletion developed superior antitumor responses because of expansion of tumor-specific cytotoxic T lymphocytes (CTLs) with increased effector function and survival. Sustained tumor control was associated with a reduction of quiescent CTLs (TCF1
Radiation enhancement using focussed ultrasound-stimulated microbubbles for breast cancer: A Phase 1 clinical trial
Authors: Daniel Moore-Palhares, Archya Dasgupta, Murtuza Saifuddin, Maria Lourdes Anzola Pena, Shopnil Prasla, Ling Ho, Lin Lu, Joseph Kung, Evan McNabb, Lakshmanan Sannachi, Danny Vesprini, Hanbo Chen, Irene Karam, Hany Soliman, Ewa Szumacher, Edward Chow, Sonal Gandhi, Maureen Trudeau, Belinda Curpen, Greg J. Stanisz, Michael Kolios, Gregory J. Czarnota
Journal: PLoS Medicine (2024)

Preclinical studies have demonstrated that tumour cell death can be enhanced 10- to 40-fold when radiotherapy is combined with focussed ultrasound-stimulated microbubble (FUS-MB) treatment. The acoustic exposure of microbubbles (intravascular gas microspheres) within the target volume causes bubble cavitation, which induces perturbation of tumour vasculature and activates endothelial cell apoptotic pathways responsible for the ablative effect of stereotactic body radiotherapy. Subsequent irradiation of a microbubble-sensitised tumour causes rapid increased tumour death. The study here presents the mature safety and efficacy outcomes of magnetic resonance (MR)-guided FUS-MB (MRgFUS-MB) treatment, a radioenhancement therapy for breast cancer.
Peroral endoscopic mediastinal tunneling myotomy for esophageal achalasia: the first case treated in mediastinal tunnel
Authors: Lijun Song, Liyun Ma, Li Wang, Guoliang Zhang, Ye Wang
Journal: Endoscopy (2024)

Peroral endoscopic myotomy (POEM) has been accepted as an effective and safe therapeutic strategy for esophageal achalasia [1]. However, the submucosal tunnel cannot be established in some patients because of severe fibrosis caused by previous treatment [2].
Peroral cholangioscopy-guided biopsy with novel biopsy forceps in comprehensive cancer genomic profiling for cystic duct carcinoma
Authors: Yujiro Kawakami, Yoshiharu Masaki, Keisuke Ishigami, Takehiro Hirano, Ayako Murota, Shintaro Sugita, Hiroshi Nakase
Journal: Endoscopy (2024)

Keywords Pancreatobiliary (ERCP/PTCD) - ERC topics - Cholangioscopy - Endoscopic ultrasonography - Biliary tract - Tissue diagnosis
Novel rendezvous technique for covered metal stent placement using balloon-assisted endoscope in duodenal perforation
Authors: Kei Saito, Yoshitomo Ishikawa, Mai Kitahara, Shuzo Nomura, Mariko Fujisawa, Hirofumi Kogure
Journal: Endoscopy (2024)

Duodenal perforations pose a significant medical challenge. While endoscopic closure can be attempted [1] [2], these cases often necessitate surgical intervention [3]. In situations where surgery carries high risks, placing a covered metal stent offers a viable alternative [4] [5]. This report describes the novel use of a covered metal stent, applied using the rendezvous technique, in treating a patient with duodenal perforation post-gastrojejunostomy ([Video 1]).
Novel self-assembling peptide for management of bleeding associated with colorectal angiodysplasia
Authors: Kenichiro Okimoto, Tomoaki Matsumura, Naoki Akizue, Yuki Ohta, Takashi Taida, Jun Kato, Naoya Kato
Journal: Endoscopy (2024)

Angiodysplasia is characterized by the presence of abnormal, ectatic, dilated, tortuous, and typically small (<10 mm) blood vessels within the gut [1]. Argon plasma coagulation is a commonly performed treatment for angiodysplasia that has proven to be effective [2]; however, perforations have been reported with this treatment [3].
A case of endoscopic ultrasonography-guided choledochoduodenostomy for malignant distal bile duct obstruction with upside-down stomach
Authors: Takuya Takayanagi, Yusuke Sekino, Kota Ueno, Shota Matsumoto, Noriki Kasuga, Hajime Nagase
Journal: Endoscopy (2024)

Endoscopic ultrasonography-guided biliary drainage (EUS-BD) is increasingly being used as a drainage technique in cases where endoscopic retrograde cholangiopancreatography (ERCP) cannot be performed. However, in patients with a massive esophageal hiatal hernia, this poses a risk of mediastinitis due to thoracic puncture. Upside-down stomach, first described in 1926 as type IV diaphragmatic hiatal hernia, is a rare condition in which a large portion of the stomach migrates into the thoracic cavity due to organoaxial rotation [1]. There have been reports of ERCP in patients with upside-down stomach [2] [3] but none of EUS-BD. This is the first report of EUS-BD for distal bile duct obstruction in a patient with pancreatic head cancer and upside-down stomach.
Deficiency of CBL and CBLB ubiquitin ligases leads to hyper T follicular helper cell responses and lupus by reducing BCL6 degradation
Authors: Xin Li, Weili Sun, Mengxing Huang, Liying Gong, Xiaochen Zhang, Li Zhong, Virginie Calderon, Zhenhua Bian, Yi He, Woong-Kyung Suh, Yang Li, Tengfei Song, Yongrui Zou, Zhe-Xiong Lian, Hua Gu
Journal: Immunity (2024)
ALDH2 polymorphism and myocardial infarction: From alcohol metabolism to redox regulation
Authors: Reece J. Lamb, Kayleigh Griffiths, Gregory Y.H. Lip, Vitaly Sorokin, Michael P. Frenneaux, Martin Feelisch, Melanie Madhani
Journal: Pharmacology & Therapeutics (2024)

Acute myocardial infarction (AMI) remains a leading cause of death worldwide. Increased formation of reactive oxygen species (ROS) during the early reperfusion phase is thought to trigger lipid peroxidation and disrupt redox homeostasis, leading to myocardial injury. Whilst the mitochondrial enzyme aldehyde dehydrogenase 2 (ALDH2) is chiefly recognised for its central role in ethanol metabolism, substantial experimental evidence suggests an additional cardioprotective role for ALDH2 independent of alcohol intake, which mitigates myocardial injury by detoxifying breakdown products of lipid peroxidation including the reactive aldehydes, malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). Epidemiological evidence suggests that an ALDH2 mutant variant with reduced activity that is highly prevalent in the East Asian population increases AMI risk. Additional studies have uncovered a strong association between coronary heart disease and this ALDH2 mutant variant. It appears this enzyme polymorphism (in particular, in ALDH2*2/2 carriers) has the potential to have wide-ranging effects on thiol reactivity, redox tone and therefore numerous redox-related signaling processes, resilience of the heart to cope with lifestyle-related and environmental stressors, and the ability of the whole body to achieve redox balance. In this review, we summarize the journey of ALDH2 from a mitochondrial reductase linked to alcohol metabolism, via pre-clinical studies aimed at stimulating ALDH2 activity to reduce myocardial injury to clinical evidence for its protective role in the heart.
Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies
Authors: Daniel J. Sheward, Pradeepa Pushparaj, Hrishikesh Das, Allison J. Greaney, Changil Kim, Sungyong Kim, Leo Hanke, Erik Hyllner, Robert Dyrdak, Jimin Lee, Xaquin Castro Dopico, Pia Dosenovic, Thomas P. Peacock, Gerald M. McInerney, Jan Albert, Martin Corcoran, Jesse D. Bloom, Ben Murrell, Gunilla B. Karlsson Hedestam, B. Martin Hällberg
Journal: Cell Reports Medicine (2024)

Descendants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant now account for almost all SARS-CoV-2 infections. The Omicron variant and its sublineages have spike glycoproteins that are highly diverged from the pandemic founder and first-generation vaccine strain, resulting in significant evasion from monoclonal antibody therapeutics and vaccines. Understanding how commonly elicited antibodies can broaden to cross-neutralize escape variants is crucial. We isolate IGHV3-53, using "public" monoclonal antibodies (mAbs) from an individual 7 months post infection with the ancestral virus and identify antibodies that exhibit potent and broad cross-neutralization, extending to the BA.1, BA.2, and BA.4/BA.5 sublineages of Omicron. Deep mutational scanning reveals these mAbs' high resistance to viral escape. Structural analysis via cryoelectron microscopy of a representative broadly neutralizing antibody, CAB-A17, in complex with the Omicron BA.1 spike highlights the structural underpinnings of this broad neutralization. By reintroducing somatic hypermutations into a germline-reverted CAB-A17, we delineate the role of affinity maturation in the development of cross-neutralization by a public class of antibodies.
Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism
Authors: Bin Li, Qi Xiao, Hongmei Zhao, Jianuo Zhang, Chunyan Yang, Yucen Zou, Bengang Zhang, Jiushi Liu, Haitao Sun, Haitao Liu
Journal: Acta Pharmaceutica Sinica B (2024)

Non-alcoholic fatty liver disease (NAFLD), characterized by hepatic steatosis, is a common metabolic liver disease worldwide. Currently, satisfactory drugs for NAFLD treatment remain lacking. Obesity and diabetes are the leading causes of NAFLD, and compounds with anti-obesity and anti-diabetic activities are considered suitable candidates for treating NAFLD. In this study, biochemical and histological assays revealed that a natural lignan schisanhenol (SAL) effectively decreased lipid accumulation and improved hepatic steatosis in free fatty acid (FFA)-treated HepG2 cells and high-fat diet (HFD)-induced NAFLD mice. Further, molecular analyses, microRNA (miRNA)-seq, and bioinformatics analyses revealed that SAL may improve NAFLD by targeting the miR-802/adenosine monophosphate-activated protein kinase (AMPK) pathway. Liver-specific overexpression of miR-802 in NAFLD mice significantly impaired SAL-mediated liver protection and decreased the protein levels of phosphorylated (p)-AMPK and PRKAB1. Dual-luciferase assay analysis further confirmed that miR-802 inhibits hepatic AMPK expression by binding to the 3ʹ untranslated region of mouse Prkab1 or human PRKAA1. Additionally, genetic silencing of PRKAA1 blocked SAL-induced AMPK pathway activation in FFA-treated HepG2 cells. The results demonstrate that SAL is an effective drug candidate for treating NAFLD through regulating miR-802/AMPK-mediated lipid metabolism.
Serial Testing of Blood Gene Expression and Donor-Derived Cell-Free DNA for Predicting Future Kidney Allograft Failure
Authors: Kexin Guo, Alexis J. Kushner, Christabel Rebello, Bradley M. Kinsella, Rohita Sinha, Lihui Zhao, John J. Friedewald, Sookhyeon Park
Journal: Journal of the American Society of Nephrology (2022)
Non-human Leukocyte Antigen (Non-HLA) Antibodies Against GSTT1 Are Associated With Homozygote Status for the Null Allele and With Histological Changes of Antibody Mediated Rejection
Authors: Bogdan Obrisca, Nicolae Leca, Elaine Chou-Wu, Gener Ismail, Idoia Gimferrer
Journal: Journal of the American Society of Nephrology (2022)
Selectively Increased Urinary Endotrophin Levels in T-Cell Mediated Kidney Transplant Rejection
Authors: Firas F. Alkaff, Daan Kremer, Daniel Guldager Kring Rasmussen, Martin Tepel, Olivier Thaunat, Marius C. van den Heuvel, Stefan P. Berger, Federica Genovese, Morten A. Karsdal, Jacob van den Born, Stephan J. Bakker
Journal: Journal of the American Society of Nephrology (2022)
Safety of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant Recipients
Authors: Tarek S. Mahmoud, Jude A. Yagan, Amal Hasan, Osama Gheith, Mohamed M. Mostafa, Suzann Rida, Mohamed Shaker, Mahmoud M. Abdrabou
Journal: Journal of the American Society of Nephrology (2022)
Safety and Clinical Efficacy of Plasma-Saving Membrane-Based Therapeutic Plasma Exchange (mTPE) in the Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
Authors: Jae Sung Ahn
Journal: Journal of the American Society of Nephrology (2022)

Journal of the American Society of Nephrology 33(11S):p 60, November 2022. | DOI: 10.1681/ASN.20223311S160b
Reno-Protective Effect of Liraglutide in Type 1 Diabetes Mellitus (T1DM): Shifting Macrophage Polarization Towards the M2 Anti-Inflammatory Phenotype Through NADPH/TRP Dual Inhibition
Authors: Natalie Youssef, Mohamad Noureldein, Fuad N. Ziyadeh, Assaad Antoine Eid
Journal: Journal of the American Society of Nephrology (2022)

Youssef, Natalie; Noureldein, Mohamad; Ziyadeh, Fuad N.; Eid, Assaad Antoine Author Information
Measured Glomerular Filtration Rate Compared to Creatinine and Cystatin C Estimating Equations in Predicting Graft Failure, Cardiovascular Events, and Death in Kidney Transplant (KTx) Recipients
Authors: Mira T. Keddis, Matthew Howard, Nan Zhang, Richard J. Butterfield, Andrew D. Rule
Journal: Journal of the American Society of Nephrology (2022)

Keddis, Mira T.; Howard, Matthew; Zhang, Nan; Butterfield, Richard J.; Rule, Andrew D. Author Information
Efficacy of Regional Citrate vs. Heparin Anticoagulation in Patients With AKI Requiring Continuous Renal Replacement Therapy: A Randomized Study
Authors: Anil Bhalla, Gaurav M. Bhandari, Vaibhav Tiwari, Vinant Bhargava, Anurag Gupta, Manish Malik, Ashwani Gupta, Devinder S. Rana
Journal: Journal of the American Society of Nephrology (2022)

Bhalla, Anil; Bhandari, Gaurav M.; Tiwari, Vaibhav; Bhargava, Vinant; Gupta, Anurag; Malik, Manish; Gupta, Ashwani; Rana, Devinder S. Author Information
A CKD Awareness Campaign and mHealth Education to Improve Knowledge and Quality of Life Among CKD Patients in Bangladesh: A Randomized Controlled Trial
Authors: Mohammad H. Sarker
Journal: Journal of the American Society of Nephrology (2022)

Journal of the American Society of Nephrology 33(11S):p 48-49, November 2022. | DOI: 10.1681/ASN.20223311S148d
Association Between Tacrolimus Level and Graft Outcome According to Bisphosphonate Use in Kidney Transplantation Patients
Authors: Hee Byung Koh, Ga Young Heo, Hyo Jeong Kim, Chan-Young Jung, Hyung Woo Kim, Seung Hwan Song, Hoon Young Choi, Jaeseok Yang, Kyu ha Huh, Beom Seok Kim
Journal: Journal of the American Society of Nephrology (2022)
Assessing the Value of “A Family Journey” Community Program for Supporting Pursuit of Preemptive Living Kidney Transplantation
Authors: Bethany Cruz, Ahmed O. Gaber, Joseph D. Sharp, Vernell Bosie, Julie Corkrean, Edward A. Graviss, Duc T. Nguyen, Alexis Bobu, Amy D. Waterman
Journal: Journal of the American Society of Nephrology (2022)

Cruz, Bethany; Gaber, Ahmed O.; Sharp, Joseph D.; Bosie, Vernell; Corkrean, Julie; Graviss, Edward A.; Nguyen, Duc T.; Bobu, Alexis; Waterman, Amy D. Author Information
Assessment of a 3-Dimensional (3D) Virtual Reality (VR) Educational Tool
Authors: Georges Nakhoul, Ali Mehdi, Alejandro Duran Crane, Jesse D. Schold, Susana Arrigain, Richard M. Wardrop, Joseph V. Nally, S. Beth Bierer, John R. Sedor, John F. O'Toole, Jonathan J. Taliercio
Journal: Journal of the American Society of Nephrology (2022)

Nakhoul, Georges; Mehdi, Ali; Crane, Alejandro Duran; Schold, Jesse D.; Arrigain, Susana; Wardrop, Richard M.; Nally, Joseph V.; Beth Bierer, S.; Sedor, John R.; O'Toole, John F.; Taliercio, Jonathan J. Author Information
Virtual NephroTalk: Teaching Communication Skills During the COVID-19 Pandemic
Authors: Alexandra E. Bursic, Amar D. Bansal, Jane O. Schell
Journal: Journal of the American Society of Nephrology (2022)

Journal of the American Society of Nephrology 33(11S):p 52, November 2022. | DOI: 10.1681/ASN.20223311S152c
Impact of Terlipressin on Serum Sodium Levels in Patients With Hepatorenal Syndrome (HRS): The North American Experience
Authors: Shehzad N. Merwat, Aftab Karim, Muhammad W. Khattak, Muhammad A. Mujtaba, Zunaira Zafar, Khurram Jamil
Journal: Journal of the American Society of Nephrology (2022)
Initiation of Terlipressin at Lower Serum Creatinine Levels Is Associated With Avoidance of Dialysis in Patients With Hepatorenal Syndrome Type 1
Authors: Juan Carlos Q. Velez, Ira Kurtz, John M. Vierling, Stevan A. Gonzalez, Khurram Jamil
Journal: Journal of the American Society of Nephrology (2022)
Qualitative Assessment of a 3-Dimensional (3D) Virtual Reality (VR) Educational Tool
Authors: Georges Nakhoul, Jonathan J. Taliercio, Bryce Montane, Susana Arrigain, Jesse D. Schold, Joseph V. Nally, Richard M. Wardrop, John F. O'Toole, S. beth Bierer, John R. Sedor, Ali Mehdi
Journal: Journal of the American Society of Nephrology (2022)

Nakhoul, Georges; Taliercio, Jonathan J.; Montane, Bryce; Arrigain, Susana; Schold, Jesse D.; Nally, Joseph V.; Wardrop, Richard M.; O'Toole, John F.; beth Bierer, S.; Sedor, John R.; Mehdi, Ali Author Information
Serum Myo-Inositol Oxygenase Levels at Hospital Discharge Predict Progression to CKD in Community-Acquired AKI
Authors: Ashok K. Yadav, Jaskiran Kaur, Kajal Kamboj, Prabhjot K. Johal, Monica Kundu, Arpita Ghosh, Jasmine Sethi, Vivek Kumar, Vivekanand Jha
Journal: Journal of the American Society of Nephrology (2022)